PACIRA BIOSCIENCES, INC. Gain (Loss) on Investments
PACIRA BIOSCIENCES, INC. (PCRX) reported Gain (Loss) on Investments of -$11.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-02.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2023-08-02
- PACIRA BIOSCIENCES, INC. gain (loss) on investments for the quarter ending 2023-06-30 was $410.00K.
- PACIRA BIOSCIENCES, INC. gain (loss) on investments for the quarter ending 2023-03-31 was -$421.00K.
- PACIRA BIOSCIENCES, INC. gain (loss) on investments for the quarter ending 2022-09-30 was -$515.00K, a 149.90% decline year-over-year.
- PACIRA BIOSCIENCES, INC. gain (loss) on investments for the quarter ending 2022-06-30 was -$38.00K.
- PACIRA BIOSCIENCES, INC. gain (loss) on investments for fiscal 2021 was -$2.67M, a 265.20% decline from fiscal 2020.
- PACIRA BIOSCIENCES, INC. gain (loss) on investments for fiscal 2020 was $1.62M.
- PACIRA BIOSCIENCES, INC. gain (loss) on investments for fiscal 2019 was -$4.32M.
- PACIRA BIOSCIENCES, INC. gain (loss) on investments for fiscal 2018 was -$854.00K.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 6 month as first filed | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|---|
| 2023-06-30 | $410.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$11.00K 10-Q · filed 2023-08-02 | |||
| 2023-03-31 | -$421.00K 10-Q · filed 2023-05-03 | ||||
| 2022-09-30 | -$515.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$553.00K derived: sum of 2 quarters · filed 2023-08-02 | -$623.00K 10-Q · filed 2022-11-03 | -$5.29M derived: sum of 4 quarters · filed 2023-08-02 | |
| 2022-06-30 | -$38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$108.00K 10-Q · filed 2023-08-02 | -$479.00K 10-Q · filed 2022-08-03 | -$4.78M derived: sum of 3 quarters · filed 2023-08-02 | -$3.75M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | -$70.00K 10-Q · filed 2023-05-03 | -$4.74M derived: sum of 2 quarters · filed 2023-05-03 | -$3.71M derived: sum of 3 quarters · filed 2023-05-03 | -$4.44M derived: sum of 4 quarters · filed 2023-05-03 | |
| 2021-12-31 | -$4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$3.64M derived: sum of 2 quarters · filed 2022-11-03 | -$4.37M derived: sum of 3 quarters · filed 2022-11-03 | -$2.67M 10-K · filed 2022-02-28 | |
| 2021-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $295.00K derived: sum of 2 quarters · filed 2022-11-03 | $2.00M 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | -$737.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $964.00K 10-Q · filed 2022-08-03 | |||
| 2021-03-31 | $1.70M 10-Q · filed 2022-05-04 | ||||
| 2020-12-31 | $1.62M 10-K · filed 2022-02-28 | ||||
| 2020-06-30 | $3.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $8.00K 10-Q · filed 2020-08-06 | -$350.00K derived: sum of 3 quarters · filed 2022-02-28 | -$4.31M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$3.97M 10-Q · filed 2020-05-07 | -$4.33M derived: sum of 2 quarters · filed 2022-02-28 | -$8.29M derived: sum of 3 quarters · filed 2022-02-28 | -$8.29M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | -$358.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$4.32M derived: sum of 2 quarters · filed 2022-02-28 | -$4.32M derived: sum of 3 quarters · filed 2022-02-28 | -$4.32M 10-K · filed 2022-02-28 | |
| 2019-09-30 | -$3.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$3.96M derived: sum of 2 quarters · filed 2020-08-06 | -$3.96M 10-Q · filed 2019-11-08 | -$3.96M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$854.00K 10-K · filed 2021-03-01 | |||
| 2018-09-30 | -$854.00K 10-Q · filed 2019-11-08 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $0.00 10-K · filed 2020-02-21 | |||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-01 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |